Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms.

Victor C UrrutiaRoland FaigleSteven R ZeilerElisabeth B MarshMona BahouthMario Cerdan TrevinoJennifer DearbornRichard LeighSusan RiceKaren LaneMustapha SaheedPeter HillRafael H Llinas

Published in: PloS one (2018)

ClinicalTrials.gov NCT01643902.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
atrial fibrillation
peritoneal dialysis
high dose
brain injury